Ardelyx (ARDX) Research & Development (2013 - 2026)
Ardelyx (ARDX) reported Research & Development of $25.2 million for Q3 2026, up 39.5% from $18.07 million a year earlier but down 3.5% from the prior quarter.
Powered by 
Analysis
Ardelyx (ARDX) Research & Development (2013 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Ardelyx's Research & Development came in at $94.35 million, up 51.3% year-over-year; for FY2025, it was $71.53 million, up 36.7% from FY2024.
- Research & Development has increased for three consecutive years, with a five-year compound annual growth rate of 1.9% (FY2020 to FY2025).
- By year, Research & Development came in at $52.32 million in FY2024 (+47.2%), $35.54 million in FY2023 (+1.0%), $35.2 million in FY2022 (-61.4%) and $91.14 million in FY2021 (+40.1%).
- Five-year quarterly Research & Development spans a low of $7.47 million in Q3 2022 and a high of $26.1 million in Q2 2026.
- Year over year, Research & Development has now increased in each of the last 13 quarters, with growth averaging 41.7% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q3 2024 (growth of 77.3%); the low point was Q3 2022 (a decline of 68.5%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $26.1 million (Q2 2026), $20.19 million (Q1 2026) and $22.86 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Ardelyx | 736.27 Mn | -333.66 Mn | 123.12 Mn | 25.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 25.20 Mn |
| Jun 30, 2026 | 26.10 Mn |
| Mar 31, 2026 | 20.19 Mn |
| Dec 31, 2025 | 22.86 Mn |
| Sep 30, 2025 | 18.07 Mn |
| Jun 30, 2025 | 15.67 Mn |
| Mar 31, 2025 | 14.94 Mn |
| Dec 31, 2024 | 13.67 Mn |
| Sep 30, 2024 | 15.31 Mn |
| Jun 30, 2024 | 12.76 Mn |
| Mar 31, 2024 | 10.58 Mn |
| Dec 31, 2023 | 9.52 Mn |
| Sep 30, 2023 | 8.64 Mn |
| Jun 30, 2023 | 8.28 Mn |
| Mar 31, 2023 | 9.09 Mn |
| Dec 31, 2022 | 9.14 Mn |
| Sep 30, 2022 | 7.47 Mn |
| Jun 30, 2022 | 9.74 Mn |
| Mar 31, 2022 | 8.85 Mn |
| Dec 31, 2021 | 20.97 Mn |
API Access
Ardelyx Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ARDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ARDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ARDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();